Reaction
Spider Naevus reporting signals
As of the last recalculation, Spider Naevus appears in 185 FAERS reports alongside 4 co-occurring drug terms. The strongest observed disproportionality signal is ADO-TRASTUZUMAB EMTANSINE (PRR 217.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ado-Trastuzumab Emtansine | 15 | 217.7 | 218.1 |
| Felodipine Extended-Release Tablets | 8 | 82.6 | 82.6 |
| Felodipine | 8 | 82.5 | 82.6 |
| Rifaximin | 10 | 56.7 | 56.7 |